Magnetar Financial LLC Immatics N.V. Transaction History

Magnetar Financial LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 14, 2021	SELL	$10.24 - $14.6 $130,344 - $185,843	-12,729 Closed	0 $0
Q4 2020 Feb 12, 2021	SELL	$9.67 - $12.05 $990,788 - $1.23 Million	-102,460 Reduced 88.95%	12,729 $137,000
Q3 2020 Nov 16, 2020	BUY	$8.73 - $15.15 $1.01 Million - $1.75 Million	115,189 New	115,189 $1.22 Million

101

75.8M

238K

727K

Ticker IMTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,227,000
Market Cap $579M
Description
Immatics N.V., a clinical-stage biopharmaceutical company, focuses on the discovery and development of T cell receptor (TCR) based immunotherapies for the treatment of cancer in the United States. The company is developing targeted immunotherapies with a focus on treating solid tumors through two distinct treatment modalities, such as adoptive c...

Get notified when there are updates to the investment portfolio of Magnetar Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Magnetar Financial LLC with notifications on news.